Here's Why Shares of Editas Medicine and Beam Therapeutics Are Soaring Today
A rumored merger has investors excited, although details are scarce.
Beam Therapeutics (BEAM)
Nasdaq Global Select
BEAM
$72.60
-$0.89
-1.2%
Price as of March 5, 2021, 9:00 p.m. EST
View Interactive BEAM Charts
Beam Therapeutics
Interactive Chart
News & Analysis: Beam Therapeutics
Gene-Editing IPO Gets Warm Reception From Investors
Beam Therapeutics' new approach offers more precision than CRISPR.
